New 52 Week High Today

Harrow Health Inc HROWL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 06/11/21 EDT
26.17quote price arrow up+0.16 (+0.60%)
Volume
19,851
52 week range
24.11 - 26.20

...

Loading . . .
  • Open26.08
  • Day High26.20
  • Day Low26.05
  • Prev Close26.01
  • 52 Week High26.20
  • 52 Week High Date06/01/21
  • 52 Week Low24.11
  • 52 Week Low Date05/07/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open26.08
  • Day High26.20
  • Day Low26.05
  • Prev Close26.01
  • 52 Week High26.20
  • 52 Week High Date06/01/21
  • 52 Week Low24.11
  • 52 Week Low Date05/07/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harrow Health Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Harrow Health, Inc owns a portfolio of healthcare and ophthalmology pharmaceutical business, including ImprimisRx, an ophthalmology outsourcing facility and pharmaceutical compounding business. The Company holds interest in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals. The Company also owns royalty rights in four clinical stage drug candidates, which is being developed by Surface Ophthalmics and Melt Pharmaceuticals.
Robert Kammer
Non-Executive Chairman
Mark Baum J.D.
Chief Executive Officer
Andrew Boll
Chief Financial Officer
Address
102 WOODMONT BLVD, SUITE 610
Nashville, TN
37215
United States